Literature DB >> 32893302

Long-term use of antibiotics and risk of type 2 diabetes in women: a prospective cohort study.

Jinqiu Yuan1,2,3,4, Yanhong Jessika Hu5,6, Jie Zheng7, Jean Hee Kim4, Tim Sumerlin4, Youpeng Chen8, Yulong He3, Changhua Zhang3, Jinling Tang9, Yihang Pan2, Michael Moore10.   

Abstract

BACKGROUND: Accumulating evidence suggested that long-term antibiotic use may alter the gut microbiome, which has, in turn, been linked to type 2 diabetes. We undertook this study to investigate whether antibiotic use was associated with increased risk of type 2 diabetes.
METHODS: This prospective cohort study included women free of diabetes, cardiovascular disease and cancer in the Nurses' Health Study (NHS 2008-2014) and NHS II (2009-2017). We evaluated the overall duration of antibiotics use in the past 4 years and subsequent diabetes risk with Cox proportional-hazards regression adjusting for demography, family history of diabetes and lifestyle factors.
RESULTS: Pooled analyses of NHS and NHS II (2837 cases, 703 934 person-years) revealed that a longer duration of antibiotic use in the past 4 years was associated with higher risk of diabetes [Trend-coefficient = 0.09, 95% confidence interval (CI) 0.04 to 0.13]. Participants who received antibiotics treatment for a medium duration of 15 days to 2 months [hazard ratio (HR) 1.23, 95% CI 1.10 to 1.39] or long duration of >2 months (HR 1.20, 95% CI 1.02 to 1.38) had higher risk of type 2 diabetes as compared with non-users. Subgroup analyses suggested that the associations were unlikely to be modified by age, family history of diabetes, obesity, smoking, alcohol drinking, physical activity and overall diet quality.
CONCLUSIONS: A longer duration of antibiotic use in recent years was associated with increased risk of type 2 diabetes in women. Physicians should exercise caution when prescribing antibiotics, particularly for long-term use.
© The Author(s) 2020; all rights reserved. Published by Oxford University Press on behalf of the International Epidemiological Association.

Entities:  

Keywords:  Antibiotics; Health Studies; Nurses’; gut microbiota; prospective cohort study; type 2 diabetes

Mesh:

Substances:

Year:  2020        PMID: 32893302      PMCID: PMC7746404          DOI: 10.1093/ije/dyaa122

Source DB:  PubMed          Journal:  Int J Epidemiol        ISSN: 0300-5771            Impact factor:   7.196


  36 in total

1.  Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation.

Authors:  Les Dethlefsen; David A Relman
Journal:  Proc Natl Acad Sci U S A       Date:  2010-09-16       Impact factor: 11.205

Review 2.  Evaluating Causality of Gut Microbiota in Obesity and Diabetes in Humans.

Authors:  Abraham S Meijnikman; Victor E Gerdes; Max Nieuwdorp; Hilde Herrema
Journal:  Endocr Rev       Date:  2018-04-01       Impact factor: 19.871

3.  Association of antibiotics in infancy with early childhood obesity.

Authors:  L Charles Bailey; Christopher B Forrest; Peixin Zhang; Thomas M Richards; Alice Livshits; Patricia A DeRusso
Journal:  JAMA Pediatr       Date:  2014-11       Impact factor: 16.193

4.  A metagenome-wide association study of gut microbiota in type 2 diabetes.

Authors:  Junjie Qin; Yingrui Li; Zhiming Cai; Shenghui Li; Jianfeng Zhu; Fan Zhang; Suisha Liang; Wenwei Zhang; Yuanlin Guan; Dongqian Shen; Yangqing Peng; Dongya Zhang; Zhuye Jie; Wenxian Wu; Youwen Qin; Wenbin Xue; Junhua Li; Lingchuan Han; Donghui Lu; Peixian Wu; Yali Dai; Xiaojuan Sun; Zesong Li; Aifa Tang; Shilong Zhong; Xiaoping Li; Weineng Chen; Ran Xu; Mingbang Wang; Qiang Feng; Meihua Gong; Jing Yu; Yanyan Zhang; Ming Zhang; Torben Hansen; Gaston Sanchez; Jeroen Raes; Gwen Falony; Shujiro Okuda; Mathieu Almeida; Emmanuelle LeChatelier; Pierre Renault; Nicolas Pons; Jean-Michel Batto; Zhaoxi Zhang; Hua Chen; Ruifu Yang; Weimou Zheng; Songgang Li; Huanming Yang; Jian Wang; S Dusko Ehrlich; Rasmus Nielsen; Oluf Pedersen; Karsten Kristiansen; Jun Wang
Journal:  Nature       Date:  2012-09-26       Impact factor: 49.962

5.  An obesity-associated gut microbiome with increased capacity for energy harvest.

Authors:  Peter J Turnbaugh; Ruth E Ley; Michael A Mahowald; Vincent Magrini; Elaine R Mardis; Jeffrey I Gordon
Journal:  Nature       Date:  2006-12-21       Impact factor: 49.962

6.  Diagnosed and Undiagnosed Diabetes Prevalence by County in the U.S., 1999-2012.

Authors:  Laura Dwyer-Lindgren; Johan P Mackenbach; Frank J van Lenthe; Abraham D Flaxman; Ali H Mokdad
Journal:  Diabetes Care       Date:  2016-09       Impact factor: 19.112

7.  Physical activity and television watching in relation to risk for type 2 diabetes mellitus in men.

Authors:  F B Hu; M F Leitzmann; M J Stampfer; G A Colditz; W C Willett; E B Rimm
Journal:  Arch Intern Med       Date:  2001-06-25

Review 8.  The risk of infections associated with rheumatoid arthritis, with its comorbidity and treatment.

Authors:  Joachim Listing; Kerstin Gerhold; Angela Zink
Journal:  Rheumatology (Oxford)       Date:  2012-11-28       Impact factor: 7.580

9.  Gut microbiota from twins discordant for obesity modulate metabolism in mice.

Authors:  Vanessa K Ridaura; Jeremiah J Faith; Federico E Rey; Jiye Cheng; Alexis E Duncan; Andrew L Kau; Nicholas W Griffin; Vincent Lombard; Bernard Henrissat; James R Bain; Michael J Muehlbauer; Olga Ilkayeva; Clay F Semenkovich; Katsuhiko Funai; David K Hayashi; Barbara J Lyle; Margaret C Martini; Luke K Ursell; Jose C Clemente; William Van Treuren; William A Walters; Rob Knight; Christopher B Newgard; Andrew C Heath; Jeffrey I Gordon
Journal:  Science       Date:  2013-09-06       Impact factor: 47.728

10.  The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing.

Authors:  Les Dethlefsen; Sue Huse; Mitchell L Sogin; David A Relman
Journal:  PLoS Biol       Date:  2008-11-18       Impact factor: 8.029

View more
  7 in total

1.  Training to Conduct Research on Religion, Spirituality and Health: A Commentary.

Authors:  Harold G Koenig; Jill B Hamilton; Benjamin R Doolittle
Journal:  J Relig Health       Date:  2021-02-02

2.  Antibiotic Consumption Patterns in European Countries Might Be Associated with the Prevalence of Type 1 and 2 Diabetes.

Authors:  Gábor Ternák; Márton Németh; Martin Rozanovic; Lajos Bogár
Journal:  Front Endocrinol (Lausanne)       Date:  2022-05-06       Impact factor: 6.055

Review 3.  Intestinal Microbiota-A Promising Target for Antiviral Therapy?

Authors:  Mengling Yang; Yang Yang; Qingnan He; Ping Zhu; Mengqi Liu; Jiahao Xu; Mingyi Zhao
Journal:  Front Immunol       Date:  2021-05-12       Impact factor: 7.561

4.  Human Gut Antibiotic Resistome and Progression of Diabetes.

Authors:  Menglei Shuai; Guoqing Zhang; Fang-Fang Zeng; Yuanqing Fu; Xinxiu Liang; Ling Yuan; Fengzhe Xu; Wanglong Gou; Zelei Miao; Zengliang Jiang; Jia-Ting Wang; Lai-Bao Zhuo; Yu-Ming Chen; Feng Ju; Ju-Sheng Zheng
Journal:  Adv Sci (Weinh)       Date:  2022-02-10       Impact factor: 16.806

5.  Association between antibiotics use and diabetes incidence in a nationally representative retrospective cohort among Koreans.

Authors:  Sun Jae Park; Young Jun Park; Jooyoung Chang; Seulggie Choi; Gyeongsil Lee; Joung Sik Son; Kyae Hyung Kim; Yun Hwan Oh; Sang Min Park
Journal:  Sci Rep       Date:  2021-11-04       Impact factor: 4.379

6.  An Engineered λ Phage Enables Enhanced and Strain-Specific Killing of Enterohemorrhagic Escherichia coli.

Authors:  Menglu Jin; Jingchao Chen; Xueyang Zhao; Guoru Hu; Hailei Wang; Zhi Liu; Wei-Hua Chen
Journal:  Microbiol Spectr       Date:  2022-07-25

7.  An Engineered Multimodular Enzybiotic against Methicillin-Resistant Staphylococcus aureus.

Authors:  Salim Manoharadas; Mohammad Altaf; Abdulwahed Fahad Alrefaei; Naushad Ahmad; Shaik Althaf Hussain; Basel F Al-Rayes
Journal:  Life (Basel)       Date:  2021-12-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.